NEUE insider trading

NeueHealth, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
508
Last 90 days
0
Buys / sells
0% / 23%
Market cap

NEUE insider activity at a glance

FilingIQ has scored 508 insider transactions for NEUE since Mar 6, 2024. The most recent filing in our index is dated Oct 2, 2025.

Across the full history, 0 open-market purchases and 118 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NEUE insider trades is 57.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest NEUE Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Top insiders trading NEUE

Frequently asked

How many insider trades does FilingIQ track for NEUE?
FilingIQ tracks 508 Form 4 insider transactions for NEUE (NeueHealth, Inc.), covering filings from Mar 6, 2024 onwards. 0 of those were filed in the last 90 days.
Are NEUE insiders net buyers or net sellers?
Across the full Form 4 history for NEUE, 0 transactions (0%) were open-market purchases and 118 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NEUE insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every NEUE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.